Serum γ-glutamyltransferase: Independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease

Obesity

Volumn 20, Issue 4, 2012, Pages 842-848

  Onat, Altan ^a   Can, Günay ^a   Örnek, Ender ^b   Çiçek, Gökhan ^c   Ayhan, Erkan ^c   Doan, Yüksel ^d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Etlik Educational and Research Hospital ^*  (Turkey)

^c DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d Bakirkoy Sadi Konuk Education and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CARDIOMETABOLIC RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; ENZYME ACTIVITY; ETHNICITY; FATTY LIVER; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HAZARD RATIO; HEALTH HAZARD; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MALE; MENOPAUSE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; SMOKING;

COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; INSULIN; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TRIGLYCERIDES;

EID: 84859216679     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.136     Document Type: Article

References (29)

1. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
2. Lee DS, Evans JC, Robins SJ et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007;27:127-133. (Pubitemid 46360389)
3. Lim JS, Yang JH, Chun BY et al. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med 2004;37:1018-1023.
4. Urakawa H, Katsuki A, Sumida Y et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003;88:4673-4676. (Pubitemid 37357510)
5. Nilssen O, F̈de OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Troms?Study. Am J Epidemiol 1994;139:787-792. (Pubitemid 24135782)
6. Yamada Y, Ikai E, Tsuritani I et al. The relationship between serum gammaglutamyl transpeptidase levels and hypertension: common in drinkers and nondrinkers. Hypertens Res 1995;18:295-301. (Pubitemid 26035607)
7. Miura K, Nakagawa H, Nakamura H et al. Serum gamma-glutamyl transferase level in predicting hypertension among male drinkers. J Hum Hypertens 1994;8:445-449. (Pubitemid 24195759)
8. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732-737. (Pubitemid 28487063)
9. Lee DH, Ha MH, Kim JH et al. Gamma-glutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia 2003;46:359-364.
10. Nakanishi N, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004;27:1427-1432. (Pubitemid 38679993)
11. Onat A, Hergen G, Karabulut A et al. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Prev Med 2006;43:136-139. (Pubitemid 44175542)
12. Hopkins PN, Wu LL, Hunt SC et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996;16:250-255. (Pubitemid 26056243)
13. Lin JP, O'Donnell CJ, Schwaiger JP et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006;114:1476-1481. (Pubitemid 44527002)
14. Giral P, Ratziu V, Couvert P et al. Plasma bilirubin and gammaglutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: relevance to oxidative stress. Atherosclerosis 2010;210:607-613.
15. Onat A, Ceyhan K, Basar O et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 2002;165:285-292. (Pubitemid 35339372)
16. Onat A, Hergen G. Low-grade inflammation and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. Metabolism 2011;60:499-512.
17. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001;156:1-10. (Pubitemid 32429589)
18. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods, 2nd edn. WHO: Geneva, 1982, pp 124-127.
19. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
20. Genuth S, Alberti KG, Bennett P et al.; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
21. Onat A, Uyarel H, Hergen G et al. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007;191:182-190. (Pubitemid 46237629)
22. Onat A, Can G, Kaya H, Hergen G. "Atherogenic index of plasma" (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 2010;4:89-98.
23. Ruttmann E, Brant LJ, Concin H et al.; Vorarlberg Health Monitoring and Promotion Program Study Group. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-2137. (Pubitemid 41475806)
24. Meisinger C, L̈el H, Heier M, Schneider A, Thorand B; KORA Study Group. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med 2005;258:527-535. (Pubitemid 41705393)
25. Onat A, Hergen G, Karabulut A et al. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. Metabolism 2007;56:1356-1362. (Pubitemid 47407754)
26. Fraser A, Harris R, Sattar N et al. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007;27:2729-2735. (Pubitemid 350158929)
27. Onat A, Can G, Ÿsel H et al. An algorithm to predict risk of type-2 diabetes in Turkish adults: contribution of C-reactive protein. J Endocrinol Invest 2010; e-pub ahead of print 27 October 2010.
28. Ikai E, Honda R, Yamada Y. Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens 1994;8:95-100. (Pubitemid 24065895)
29. Yin M, Wheeler MD, Kono H et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-952. (Pubitemid 29468238)